Startup Iambic Raises $100M for Clinical Trials of AI-Discovered Cancer Drugs

Iambic’s latest financing follows the presentation of data for its breast cancer drug during the recent European Society of Medical Oncology conference. Our financing roundup includes capital raised by startups developing novel therapies immunology, metabolic disorders, genetic diseases, and more. The post Startup Iambic Raises $100M for Clinical Trials of AI-Discovered Cancer Drugs appeared first…

Read More

Five Building Blocks to a Resilient Healthcare Cybersecurity Culture

By Edward Myers, National Director of Cyber Security, Crothall Healthcare Technology Solutions (HTS) US hospitals are stepping up their defenses against cybersecurity attacks.Much of the focus on recent cyber spending is in response to the February 2024 hack of payments manager Change Healthcare. A whopping 94 percent of American Hospital Association members reported suffering a…

Read More

MIT Spinout Syntis Bio Secures $38M for a Novel Approach to Treating Obesity and More

Instead of an engineered peptide to activate gut receptors to trigger metabolic effects, Syntis’s technology forms a coating in intestines that has the effect of redirecting nutrients, mimicking an effect of gastric bypass surgery. In other obesity medicine news, Protagonist Therapeutics revealed a drug candidate that puts it in competition with Novo Nordisk and Eli…

Read More

Carving a Path Toward Pragmatic Innovation in Clinical Trials

Prioritizing risk-based management, data science, smart automation, standards, and patient optionality are critical for the industry to keep up with market changes. The recent FDA guidance that encourages ‘pragmatic trials’ in specific scenarios is a move in the right direction. The post Carving a Path Toward Pragmatic Innovation in Clinical Trials appeared first on MedCity…

Read More

Watching Where and How You’re Walking

By MIKE MAGEE In a speech to the American Philosophical Society in January, 1946, J. Robert Oppenheimer said, “We have made a thing …that has altered abruptly and profoundly the nature of the world…We have raised again the question of whether science is good for man, of whether it is good to learn about the…

Read More